Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Microcap Kitchen Canadian Stocks -- Ignore unavailable to you. Want to Upgrade?

To: Boolish who wrote (24573)	5/31/2014 12:07:19 AM
From: Hodor	Read Replies (1) \| Respond to of 49402

TLT is presenting on Monday in Vancouver for anyone already going cambridgehouse.com

To: Boolish who wrote (24573)	5/31/2014 7:07:34 AM
From: ogi	1 Recommendation Recommended By pocotrader Respond to of 49402

Not much difference between a biotech spec and jr. explorer spec in that they both burn cash pursuing the motherlode with terrible odds of success. Nothing ever happens according to expected timelines so it really helps that TLT has a viable underlying business in the meantime. I like the position I have but would like more in order to trade on future moves and keep what I have as a core in case this pans out. The PDC 's they use are basically inert until activated by light, little worry about safety profile. Any positive efficacy in first trial will have accelerated implications compared to most lengthy trial processes. That I assume will be at least a year away. A pleasant interim development might be a collaboration on the bacteria destruction capabilities, could be a large opportunity in medical and food processing applications. Some more animal studies still to be announced as I recall something regarding rat models. Glad you have an entry, plenty of time to adjust the position as things unfold. P.S. holding all Ptg, added back small traders last week at .15 . Three quarters of improving numbers, service revenues growing appreciably. At some time the miniscule market cap gets adjusted upward, risk reward ratio remains very levered to success IMO.